Norepinephrine metabolites in plasma as indicators of pharmacological inhibition of monoamine oxidase and catechol O-methyltransferase

Adv Pharmacol. 1998:42:367-70. doi: 10.1016/s1054-3589(08)60767-x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparkinson Agents / pharmacology
  • Benzamides / pharmacology
  • Biomarkers / blood
  • Catechol O-Methyltransferase Inhibitors*
  • Catechols / pharmacology*
  • Chromatography, High Pressure Liquid
  • Humans
  • Male
  • Methoxyhydroxyphenylglycol / analogs & derivatives*
  • Methoxyhydroxyphenylglycol / blood*
  • Moclobemide
  • Monoamine Oxidase / metabolism*
  • Monoamine Oxidase Inhibitors / pharmacology*
  • Nitriles
  • Norepinephrine / analogs & derivatives
  • Norepinephrine / blood*
  • Pentanones / pharmacology
  • Selegiline / pharmacology

Substances

  • Antiparkinson Agents
  • Benzamides
  • Biomarkers
  • Catechol O-Methyltransferase Inhibitors
  • Catechols
  • Monoamine Oxidase Inhibitors
  • Nitriles
  • Pentanones
  • Selegiline
  • entacapone
  • Methoxyhydroxyphenylglycol
  • nitecapone
  • Monoamine Oxidase
  • Moclobemide
  • 3,4-dihydroxyphenylglycol
  • Norepinephrine